These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26051842)

  • 1. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.
    Shishodia G; Shukla S; Srivastava Y; Masaldan S; Mehta S; Bhambhani S; Sharma S; Mehrotra R; Das BC; Bharti AC
    Mol Cancer; 2015 Jun; 14():116. PubMed ID: 26051842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein.
    Shishodia G; Verma G; Srivastava Y; Mehrotra R; Das BC; Bharti AC
    BMC Cancer; 2014 Dec; 14():996. PubMed ID: 25539644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus 16 E6 modulates the expression of host microRNAs in cervical cancer.
    Ben W; Yang Y; Yuan J; Sun J; Huang M; Zhang D; Zheng J
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):364-70. PubMed ID: 26384051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection.
    Shukla S; Shishodia G; Mahata S; Hedau S; Pandey A; Bhambhani S; Batra S; Basir SF; Das BC; Bharti AC
    Mol Cancer; 2010 Oct; 9():282. PubMed ID: 20977777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways.
    Yao S; Xu J; Zhao K; Song P; Yan Q; Fan W; Li W; Lu C
    Cell Death Dis; 2018 Oct; 9(11):1055. PubMed ID: 30333561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
    Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
    Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
    Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
    Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
    Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
    Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Guo M; Zhao X; Yuan X; Jiang J; Li P
    Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
    Ren C; Cheng X; Lu B; Yang G
    Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
    Liu X
    Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of phospho-STAT3 (Tyr705) correlates with copy number and physical state of human papillomavirus 16 genome in cervical precancer and cancer lesions.
    Shukla S; Jadli M; Thakur K; Shishodia G; Mahata S; Basir SF; Das BC; Bharti AC
    PLoS One; 2019; 14(9):e0222089. PubMed ID: 31487312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells.
    Liu C; Lin J; Li L; Zhang Y; Chen W; Cao Z; Zuo H; Chen C; Kee K
    Sci Rep; 2015 Jan; 5():7653. PubMed ID: 25563170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The STAT3-miR-223-TGFBR3/HMGCS1 axis modulates the progression of cervical carcinoma.
    Zhang J; Jiang M; Qian L; Lin X; Song W; Gao Y; Zhou Y
    Mol Oncol; 2020 Sep; 14(9):2313-2331. PubMed ID: 32491253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Profile of MicroRNA-203 and its ΔNp63 Target in Cervical Carcinogenesis: Prospects for Cervical Cancer Screening.
    Coimbra EC; DA Conceição Gomes Leitão M; Júnior MR; DE Oliveira TH; DA Costa Silva Neto J; DE Freitas AC
    Anticancer Res; 2016 Aug; 36(8):3939-46. PubMed ID: 27466497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance.
    Yang Y; Xie YJ; Xu Q; Chen JX; Shan NC; Zhang Y
    Gynecol Oncol; 2015 Sep; 138(3):683-8. PubMed ID: 26074491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway.
    Wongjampa W; Ekalaksananan T; Chopjitt P; Chuerduangphui J; Kleebkaow P; Patarapadungkit N; Pientong C
    PLoS One; 2018; 13(10):e0206644. PubMed ID: 30379969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.